moelis & co. - MC
MC
Close Chg Chg %
66.23 1.06 1.59%
Open Market
67.29
+1.06 (1.59%)
Volume: 230.29K
Last Updated:
Jul 9, 2025, 12:47 PM EDT
Company Overview: moelis & co. - MC
MC Key Data
| Open $66.52 | Day Range 66.49 - 67.70 |
| 52 Week Range 47.01 - 82.89 | Market Cap $4.91B |
| Shares Outstanding 74.18M | Public Float 73.39M |
| Beta 1.63 | Rev. Per Employee N/A |
| P/E Ratio 30.32 | EPS $2.33 |
| Yield 377.64% | Dividend $0.65 |
| EX-DIVIDEND DATE May 5, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 915.37K |
MC Performance
| 1 Week | 0.61% | ||
| 1 Month | 18.24% | ||
| 3 Months | 30.83% | ||
| 1 Year | 8.49% | ||
| 5 Years | 123.72% |
MC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
8
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 58.833 | |
| Number of Ratings | 8 | Current Quarters Estimate | 0.407 | |
| FY Report Date | 09 / 2025 | Current Year's Estimate | 2.081 | |
| Last Quarter’s Earnings | 0.293 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.82 | Next Fiscal Year Estimate | 2.972 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 8 | 8 | 8 | 8 |
| Mean Estimate | 0.41 | 0.71 | 2.08 | 2.97 |
| High Estimates | 0.61 | 0.94 | 2.70 | 3.50 |
| Low Estimate | 0.28 | 0.49 | 1.66 | 2.59 |
| Coefficient of Variance | 27.33 | 18.00 | 13.83 | 12.19 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 1 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 5 | 5 | 5 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 1 | 1 | 3 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Moelis & Co. - MC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Moelis & Co. - MC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 24, 2025 | Jeffrey Raich Co-President, MD | 63,517 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Osamu R. Watanabe General Counsel, Secretary | 12,132 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $74 per share | 897,768.00 |
| Feb 24, 2025 | Osamu R. Watanabe General Counsel, Secretary | 12,135 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Eric Cantor Vice Chairman, MD; Director | 25,855 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Kenneth David Moelis Chairman, CEO; Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Kenneth David Moelis Chairman, CEO; Director | 209,235 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $74 per share | 15,483,390.00 |
| Feb 24, 2025 | Kenneth David Moelis Chairman, CEO; Director | 218,947 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $74 per share | 16,202,078.00 |
| Feb 24, 2025 | Kenneth David Moelis Chairman, CEO; Director | 218,948 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Jeffrey Raich Co-President, MD | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Jeffrey Raich Co-President, MD | 54,794 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $74 per share | 4,054,756.00 |
| Feb 24, 2025 | Jeffrey Raich Co-President, MD | 63,516 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $74 per share | 4,700,184.00 |
| Feb 24, 2025 | Joe W. Simon Chief Financial Officer | 28,591 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Navid Mahmoodzadegan Co-President, MD | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Navid Mahmoodzadegan Co-President, MD | 197,602 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $74 per share | 14,622,548.00 |
| Feb 24, 2025 | Navid Mahmoodzadegan Co-President, MD | 207,008 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $74 per share | 15,318,592.00 |
| Feb 24, 2025 | Navid Mahmoodzadegan Co-President, MD | 207,009 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Kenneth L. Shropshire Director | 6,940 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $72.3 per share | 501,762.00 |
| Feb 24, 2025 | Joe W. Simon Chief Financial Officer | 4,358 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Joe W. Simon Chief Financial Officer | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Joe W. Simon Chief Financial Officer | 22,832 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $74 per share | 1,689,568.00 |